Search for: "Tom Lamb" Results 221 - 240 of 1,044
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Aug 2008, 9:50 pm
Most Of These Product Liability Cases Allege Fosamax Caused Drug-Induced Osteonecrosis Of The Jaw (ONJ) (Posted by Tom Lamb at DrugInjuryWatch.com) According to an August 14, 2008 "MERCK & CO: Faces 655 Product Liability Cases Over Fosamax Drug", published by Lloyds Corporate Litigation Reporter:   Merck & Co., Inc., as of June 30, 2008, faced approximately 655  product liability cases involving Fosamax drug, including about… [read post]
6 Sep 2007, 2:56 pm
Antibiotic Ketek Restricted To Certain Types Of Pneumonia; No Longer Used For Sinusitis, Bronchitis, Tonsillitis, Pharyngitis (Posted by Tom Lamb at DrugInjuryWatch.com) On September 5, 2007 Health Canada issued by email a MedEffect alert about Ketek which included this summary:Sanofi-aventis Canada, Inc. is informing Canadians that the antibiotic Ketek (telithromycin), should no longer be used to treat sinusitis, bronchitis, tonsillitis or pharyngitis. [read post]
20 Aug 2008, 8:04 pm
Various Parties Have Filed Briefs  With Their  Arguments About Whether  Or Not  An Injured Patient Should Be Able To File A  Lawsuit Against  The Drug Company (Posted by Tom Lamb at DrugInjuryWatch.com) As some of you are aware by now, this fall the Supreme Court will hear oral arguments in the case Wyeth v. [read post]
13 Jan 2011, 1:55 pm by Tom Lamb
2011 Raptiva Lawsuit Filed In Texas Against Drug Company: Failure To Warn About Side Effect Risks (Posted by Tom Lamb at DrugInjuryWatch.com)Back in 2009 we told you about some of the developments which led to Raptiva being withdrawn from the market in these two articles: -- A Timeline For The Psoriasis Drug Raptiva, From Product Launch In U.S. [read post]
10 May 2007, 7:41 am
(Posted by Tom Lamb at DrugInjuryWatch.com) Natrecor (nesiritide) is approved for the treatment of patients with acutely decompensated heart failure who suffer from symptoms at rest or with minimal exertion. [read post]
19 Aug 2011, 1:55 pm by Tom Lamb
New Sanofi "Dear Doctor" Letter: Label Change Regarding Heart-Related Side Effects Coming Soon (Posted by Tom Lamb at DrugInjuryWatch.com)This August 2011 update on Multaq (dronedarone) covers both liver injury and cardiovascular side effects. [read post]
12 Sep 2012, 1:45 pm by Tom Lamb
Heart Drug Multaq Can Cause Pulmonary Fibrosis And Pneumonitis; Symptoms Are Inflammation Of The Lungs, Including Scarring And Thickening (Posted by Tom Lamb at DrugInjuryWatch.com) Multaq (dronedarone) is a drug used to treat abnormal heart rhythm (atrial fibrillation or atrial flutter). [read post]
29 May 2008, 7:43 am
Confusion Between Similar Drugs Is A Cause Of Medication Errors That Agency Will Focus On In New Pilot Program (Posted by Tom Lamb at DrugInjuryWatch.com) To start, we get this background information from "Medication Errors: FDA 101", which was posted March 14, 2008 on the FDA's web site: A medication error is any preventable event that may cause or lead to inappropriate medication use or harm to a patient. [read post]
3 Mar 2011, 12:58 pm by Tom Lamb
Adverse Reactions And Warnings Sections Now Include Hepatotoxicity, From Hepatic Dysfunction To Liver Failure  (Posted by Tom Lamb at DrugInjuryWatch.com) The association between the antibiotic Zithromax (azithromycin) and drug-induced liver failure first received some real attention in 2010. [read post]
26 Apr 2007, 2:58 pm
Findings Of April 2007 AHRQ Report On Side Effects And Other Medication Problems In American Hospitals (Posted by Tom Lamb at DrugInjuryWatch.com) A recent online article provided a summary of the findings from the "Adverse Drug Events in U.S. [read post]
30 Dec 2010, 11:30 am by Tom Lamb
SJS And TEN Differ In The Extent Of Skin Detachment, But Both Are Severe And Life-Threatening Drug Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) Stevens-Johnson syndrome (SJS) was first described in 1922, and toxic epidermal necrolysis (TEN) was first described in 1956. [read post]
27 Jan 2009, 3:00 pm
(Posted by Tom Lamb at DrugInjuryWatch.com) In the most recent FDA Drug Safety Newsletter (Volume 2, Number 1, 2009) we found a report, "Atomoxetine (Marketed as Strattera): Serious Liver Injury", that is rather disturbing insofar that the majority of patients at risk are children. [read post]
19 Jun 2013, 2:50 pm by Tom Lamb
Number Of NuvaRing Lawsuits Filed Against Merck Increases, And More Evidence That NuvaRing Causes Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), And Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com)During the past year we have reported periodically on the NuvaRing drug injury lawsuits -- both the federal court NuvaRing MDL pending before Judge Rodney Sippel and the New Jersey state court consolidated NuvaRing litigation being handled by Judge Brian… [read post]
26 Jul 2013, 2:18 pm by Tom Lamb
We will continue to monitor this emerging drug safety issue involving acute kidney injury -- as well as the association between retinal detachment and fluoroquinolones, e.g., Levaquin, Cipro, Avelox -- and report further developments here. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects  (All website content by attorney Tom Lamb) Drug Injury Case… [read post]
4 Sep 2013, 12:50 pm by Tom Lamb
We will continue to monitor Bayer's efforts to negotiate settlements at mediations with plaintiffs' attorneys across the country -- as more YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral lawsuits are filed on behalf of women who suffered a deep vein thrombosis (DVT) and/or a pulmonary embolism (PE), including some who died, unfortunately. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side… [read post]